By Abhishek Vishnoi
MUMBAI (Reuters) - The BSE Sensex edged higher amid volatility caused due to the expiry of the September equity derivative contracts on Thursday, led by Sun Pharma, which rose to an all-time high on hopes of higher sales of a key cancer drug.
Financial shares gained after the Reserve Bank of India (RBI) said on Wednesday it would take action, including conducting open market operations, to ensure adequate liquidity is available in the banking system and acknowledged liquidity conditions had been tightening.
Traders say the markets may at best consolidate around the current levels as earnings reports, which are not expected to spring any positive surprises, would be in focus during October while the general elections would become the main focus in November.
"Focus would be on earnings but only very few players are going to report profit growth, so expect the market to remain dull and sideways for now" said Jyotheesh Kumar, executive vice president of HDFC Securities,
Also Read
The BSE index rose 0.19 percent, or 37.61 points, to end at 19,893.85.
The broader NSE index rose 0.14 percent, or 8.40 points, to end at 5,882.25, taking support around its 200-day moving average for the third consecutive day.
Sun Pharmaceutical Industries Ltd
The expected shortage in supply is due to an interruption from the company's supplier, Ben Venue Laboratories Inc, J&J said.
Financial shares that benefited from RBI's assurance on liquidity included ICICI Bank Ltd
Shares in Gillette India Ltd
Indian software services exporter Wipro Ltd
Reliance Infrastructure Ltd
JSW Steel Ltd
(Editing by Anupama Dwivedi)